Base to Base biotech podcast 47: Accurate prostate cancer diagnosis and ocular gene therapy
Modifying CAR T-cells to kill solid tumours
New company created to tackle paediatric cerebral palsy
Strategic partnership to advance space-based life sciences research infrastructure
Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation
World’s first gene-editing therapy for hyperlipidemia
Positive results for Lilly obesity drug
“Foundational moment for in vivo cell therapy”
Cooperative motor proteins kill cancer cells when dual-inhibited
SanegeneBio announces collaboration with Lilly
Amgen reveals cardiovascular drug results
Pila Pharma’s capital raise oversubscribed by 293% to fund obesity studies